Assignee
EXTROVIS AG
CH·6 granted patents·4 pending applications·0 citations·filing 2021–2025
Top patents by PatentIndex Score
10 records- 0164US2025144015A1Pharmaceutical CompositionsEXTROVIS AG·Filed 2024·Application pending·0 cites
- 0257US12569434B2Formulations of NebivololEXTROVIS AG·Filed 2023·Granted Mar 10, 2026·0 cites·7 claims
- 0352US11278634B1Stable parenteral composition of lacosamideEXTROVIS AG·Filed 2021·Granted Mar 22, 2022·0 cites·10 claims
- 0450US12576026B2Formulations of nebivololEXTROVIS AG·Filed 2021·Granted Mar 17, 2026·0 cites·5 claims
- 0550US11642358B1Stable pharmaceutical formulationEXTROVIS AG·Filed 2022·Granted May 9, 2023·0 cites·10 claims
- 0650US11541066B2Stable ready-to-use parenteral compositions of fosaprepitantEXTROVIS AG·Filed 2022·Granted Jan 3, 2023·0 cites·8 claims
- 0749US12303506B2Trabectedin compositionEXTROVIS AG·Filed 2022·Granted May 20, 2025·0 cites·10 claims
- 0846US2024123021A1Pharmaceutical compositionsEXTROVIS AG·Filed 2022·Application pending·0 cites
- 0946US2023062279A1Pharmaceutical compositions of bortezomibEXTROVIS AG·Filed 2022·Application pending·0 cites
- 1035US2025345336A1Allopurinol oral suspensionEXTROVIS AG·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when EXTROVIS AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →